NT-proBNP is metabolized by the kidneys and is greatly affected by renal function, and ACE inhibitors/ARBs, β-blockers, adrenergic antagonists, and diuretics can reduce the concentration of NT-proBNP, so it is necessary to measure the basal level of NT-proBNP before drug treatment as a reference for diagnosis, prognosis, and efficacy evaluation.